Cardio-Phoenix News & Updates

Explore our latest announcements, insights, event highlights, published research, and real-world use cases of Cardio-HART.

Insights
ECG Is Failing Us — and Guidelines Already Know It
January 23, 2026
A clinical opinion inspired by a real case from ESC Congress, Madrid 2025 ECG is failing us when it is treated as sufficient for ruling…
Read More
Announcement
A True Story: When Heart Failure Missed by ECG Confronts the Rent
January 15, 2026
Heart failure missed by ECG is not a rare exception — it is a systemic problem that continues to delay diagnosis, even when warning signs…
Read More
Insights
NT-proBNP Heart Failure Diagnosis in Primary Care: Where Current Pathways Fail and How Cardio-HART Complements Them
December 30, 2025
NT-proBNP heart failure diagnosis in primary care has long relied on biomarker-led pathways, yet remains limited—especially for patients with heart failure with preserved ejection fraction…
Read More
Insights
LVEF in Primary Care: Redefining Early Heart Failure Diagnosis
December 30, 2025
LVEF in Primary Care is becoming essential as heart failure (HF) continues to rise globally, driven by population ageing and the increasing prevalence of hypertension,…
Read More
Insights
Device-Based Heart Failure Diagnostics: Why Tools Beyond NT-proBNP Are Needed
December 29, 2025
Executive Summary Device-based heart failure diagnostics are increasingly recognized as essential to complement NT-proBNP testing. Although NT-proBNP remains central to current diagnostic pathways, clinical evidence…
Read More
Events
Cardio Phoenix Highlights Cardio-HART at MEDICA 2025 After Record Interest and 250+ Leads
December 4, 2025
DÜSSELDORF, Germany – Cardio Phoenix, a pioneer in AI-powered medical technologies, today announced a highly successful exhibition of Cardio-HART at MEDICA 2025. By showcasing its…
Read More

Stay Informed on
Cardio-HART Developments

Get clinical updates, new research, and product news—direct to your inbox.

Categories

What makes Cardio-HART a game-changer in early cardiac diagnostics?

Cardio-HART redefines how heart conditions are detected by combining advanced biosignal analysis with AI. Instead of relying solely on ECG, it captures a deeper view of the heart’s mechanical and electrical functions — enabling primary care physicians to detect complex heart diseases earlier, without waiting for specialist referrals.

How does Cardio-HART differ from traditional ECG in real-world studies?

Unlike ECG, Cardio-HART uses AI-driven algorithms combining ECG, PCG, and MCG signals to detect structural and functional heart disorders with higher sensitivity — as validated in multiple studies.

Where has Cardio-HART been presented or featured?

Cardio-HART has been presented at major European cardiology congresses and scientific publications. See our Events and Publications sections for more.

FAQ –>